{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T06:52:52Z","timestamp":1767423172676},"reference-count":72,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.vaccine.2005.10.052","type":"journal-article","created":{"date-parts":[[2005,11,10]],"date-time":"2005-11-10T12:17:48Z","timestamp":1131625068000},"page":"1928-1940","source":"Crossref","is-referenced-by-count":35,"title":["Immunogenicity of a multicomponent DNA vaccine against visceral leishmaniasis in dogs"],"prefix":"10.1016","volume":"24","author":[{"given":"Omar A.","family":"Saldarriaga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno L.","family":"Travi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis E.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter C.","family":"Melby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2005.10.052_bib1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4269\/ajtmh.1996.55.125","article-title":"The logic of visceral leishmaniasis control","volume":"55","author":"Dye","year":"1996","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.vaccine.2005.10.052_bib2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4269\/ajtmh.1996.55.273","article-title":"Canine leishmaniasis: identification of asymptomatic carriers by polymerase chain reaction and immunoblotting","volume":"55","author":"Berrahal","year":"1996","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.vaccine.2005.10.052_bib3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0304-4017(00)00446-5","article-title":"Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment","volume":"96","author":"Solano-Gallego","year":"2001","journal-title":"Vet Parasitol"},{"issue":"3","key":"10.1016\/j.vaccine.2005.10.052_bib4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0304-4017(97)00208-2","article-title":"The immunology of canine leishmaniosis: strong evidence for a developing disease spectrum from asymptomatic dogs","volume":"76","author":"Cabral","year":"1998","journal-title":"Vet Parasitol"},{"issue":"3","key":"10.1016\/j.vaccine.2005.10.052_bib5","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4269\/ajtmh.1995.52.287","article-title":"Control of zoonotic visceral leishmaniasis: is it time to change strategies?","volume":"52","author":"Tesh","year":"1995","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"10.1016\/j.vaccine.2005.10.052_bib6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0738-081X(96)00041-7","article-title":"Leishmaniasis reservoirs and their significance in control","volume":"14","author":"Ashford","year":"1996","journal-title":"Clin Dermatol"},{"issue":"1","key":"10.1016\/j.vaccine.2005.10.052_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4269\/ajtmh.1998.59.53","article-title":"Studies on control of visceral leishmaniasis: impact of dog control on canine and human visceral leishmaniasis in Jacobina, Bahia, Brazil","volume":"59","author":"Ashford","year":"1998","journal-title":"Am J Trop Med Hyg"},{"issue":"9","key":"10.1016\/j.vaccine.2005.10.052_bib8","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1086\/344312","article-title":"Infectiousness in a cohort of Brazilian dogs: why culling fails to control visceral leishmaniasis in areas of high transmission","volume":"186","author":"Courtenay","year":"2002","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2005.10.052_bib9","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1086\/516096","article-title":"Effect of eliminating seropositive canines on the transmission of visceral leishmaniasis in Brazil","volume":"25","author":"Dietze","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2005.10.052_bib10","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/jac\/36.6.1013","article-title":"Activity of liposomal amphotericin B (AmBisome) in dogs naturally infected with Leishmania infantum","volume":"36","author":"Oliva","year":"1995","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.vaccine.2005.10.052_bib11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/00034983.1994.11812879","article-title":"Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy","volume":"88","author":"Alvar","year":"1994","journal-title":"Ann Trop Med Parasitol"},{"issue":"6","key":"10.1016\/j.vaccine.2005.10.052_bib12","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/00034983.1992.11812717","article-title":"Decreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment","volume":"86","author":"Gramiccia","year":"1992","journal-title":"Ann Trop Med Parasitol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2005.10.052_bib13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0304-4017(01)00486-1","article-title":"An update on antileishmanial vaccine candidates and prospects for a canine Leishmania vaccine","volume":"100","author":"Gradoni","year":"2001","journal-title":"Vet Parasitol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2005.10.052_bib14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4269\/ajtmh.2001.64.119","article-title":"Canine visceral leishmaniasis in Colombia: relationship between clinical and parasitologic status and infectivity for sand flies","volume":"64","author":"Travi","year":"2001","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.vaccine.2005.10.052_bib15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/CMR.14.2.229-243.2001","article-title":"Leishmaniasis: current status of vaccine development","volume":"14","author":"Handman","year":"2001","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"10.1016\/j.vaccine.2005.10.052_bib16","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2165\/00128071-200203080-00006","article-title":"Vaccination against cutaneous leishmaniasis: current status","volume":"3","author":"Melby","year":"2002","journal-title":"Am J Clin Dermatol"},{"issue":"13","key":"10.1016\/j.vaccine.2005.10.052_bib17","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1089\/hum.1998.9.13-1899","article-title":"Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis","volume":"9","author":"Walker","year":"1998","journal-title":"Hum Gene Ther"},{"issue":"2","key":"10.1016\/j.vaccine.2005.10.052_bib18","first-page":"173","article-title":"Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp63, of L. major","volume":"84","author":"Xu","year":"1995","journal-title":"Immunology"},{"issue":"7","key":"10.1016\/j.vaccine.2005.10.052_bib19","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1084\/jem.186.7.1137","article-title":"Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major","volume":"186","author":"Gurunathan","year":"1997","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.vaccine.2005.10.052_bib20","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/4000","article-title":"Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection","volume":"4","author":"Gurunathan","year":"1998","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.vaccine.2005.10.052_bib21","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.4049\/jimmunol.160.8.3949","article-title":"Induction of a Th1 immune response and simultaneous lack of activation of a Th2 response are required for generation of immunity to leishmaniasis","volume":"160","author":"Sjolander","year":"1998","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2005.10.052_bib22","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1128\/IAI.69.6.4103-4108.2001","article-title":"Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease","volume":"69","author":"Campos-Neto","year":"2001","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2005.10.052_bib23","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.4049\/jimmunol.166.8.5122","article-title":"The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge","volume":"166","author":"Mendez","year":"2001","journal-title":"J Immunol"},{"issue":"15","key":"10.1016\/j.vaccine.2005.10.052_bib24","doi-asserted-by":"crossref","first-page":"8427","DOI":"10.1073\/pnas.160197797","article-title":"The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory\/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge","volume":"97","author":"Stobie","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"26","key":"10.1016\/j.vaccine.2005.10.052_bib25","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1016\/S0264-410X(00)00119-5","article-title":"DNA vaccine encoding nucleocapsid and surface proteins of wild type canine distemper virus protects its natural host against distemper","volume":"18","author":"Cherpillod","year":"2000","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2005.10.052_bib26","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0264-410X(97)00239-9","article-title":"Nucleic acid immunization protects dogs against challenge with virulent canine parvovirus","volume":"16","author":"Jiang","year":"1998","journal-title":"Vaccine"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2005.10.052_bib27","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0264-410X(98)00328-4","article-title":"Immunization of dogs and cats with a DNA vaccine against rabies virus","volume":"17","author":"Osorio","year":"1999","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2005.10.052_bib28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0165-2427(99)00132-4","article-title":"Immunization of animals: from DNA to the dinner plate","volume":"72","author":"Babiuk","year":"1999","journal-title":"Vet Immunol Immunopathol"},{"issue":"5","key":"10.1016\/j.vaccine.2005.10.052_bib29","first-page":"441","article-title":"Immune responses in vaccinated dogs with autoclaved Leishmania major promastigotes","volume":"30","author":"Lasri","year":"1999","journal-title":"Vet Res"},{"issue":"22","key":"10.1016\/j.vaccine.2005.10.052_bib30","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/j.vaccine.2004.11.061","article-title":"Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes","volume":"23","author":"Lemesre","year":"2005","journal-title":"Vaccine"},{"issue":"29\u201330","key":"10.1016\/j.vaccine.2005.10.052_bib31","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1016\/j.vaccine.2004.03.058","article-title":"Double-blind randomized efficacy field trial of alum precipitated autoclaved Leishmania major vaccine mixed with BCG against canine visceral leishmaniasis in Meshkin-Shahr district, I.R. Iran","volume":"22","author":"Mohebali","year":"2004","journal-title":"Vaccine"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2005.10.052_bib32","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0264-410X(00)00339-X","article-title":"A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (Sao Goncalo do Amaranto, RN)","volume":"19","author":"da Silva","year":"2000","journal-title":"Vaccine"},{"issue":"27\u201328","key":"10.1016\/j.vaccine.2005.10.052_bib33","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1016\/S0264-410X(02)00294-3","article-title":"Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (Sao Goncalo do Amarante, RN)","volume":"20","author":"Borja-Cabrera","year":"2002","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2005.10.052_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-2427(02)00315-X","article-title":"A Leishmania infantum multi-component antigenic protein mixed with live BCG confers protection to dogs experimentally infected with L. infantum","volume":"92","author":"Molano","year":"2003","journal-title":"Vet Immunol Immunopathol"},{"issue":"28","key":"10.1016\/j.vaccine.2005.10.052_bib35","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1016\/j.vaccine.2005.02.009","article-title":"Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantum","volume":"23","author":"Rafati","year":"2005","journal-title":"Vaccine"},{"issue":"19\u201320","key":"10.1016\/j.vaccine.2005.10.052_bib36","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/S0264-410X(03)00032-X","article-title":"Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK","volume":"21","author":"Ramiro","year":"2003","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2005.10.052_bib37","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1128\/IAI.68.10.5595-5602.2000","article-title":"Identification of vaccine candidates for experimental visceral leishmaniasis by immunization with sequential fractions of a cDNA expression library","volume":"68","author":"Melby","year":"2000","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2005.10.052_bib38","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1128\/IAI.69.8.4719-4725.2001","article-title":"Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis","volume":"69","author":"Melby","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.10.052_bib39","series-title":"Current Protocols in Immunology","first-page":"19.2.1","article-title":"Animal models for the analysis of immune responses to leishmaniasis","author":"Sacks","year":"1998"},{"issue":"1","key":"10.1016\/j.vaccine.2005.10.052_bib40","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1128\/IAI.66.1.18-27.1998","article-title":"Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani","volume":"66","author":"Melby","year":"1998","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2005.10.052_bib41","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1182\/blood.V78.4.930.930","article-title":"Molecular cloning and in vivo evaluation of canine granulocyte-macrophage colony-stimulating factor","volume":"78","author":"Nash","year":"1991","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.vaccine.2005.10.052_bib42","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0014-4894(90)90031-7","article-title":"Amplification of kinetoplast DNA as a tool in the detection and diagnosis of Leishmania","volume":"71","author":"Rodgers","year":"1990","journal-title":"Exp Parasitol"},{"issue":"20","key":"10.1016\/j.vaccine.2005.10.052_bib43","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/S0264-410X(98)00075-9","article-title":"Vaccination with recombinant parasite surface antigen 2 from Leishmania major induces a Th1 type of immune response but does not protect against infection","volume":"16","author":"Sjolander","year":"1998","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2005.10.052_bib44","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0264-410X(96)00279-4","article-title":"Polynucleotide vaccines in animals: enhancing and modulating responses","volume":"15","author":"Lewis","year":"1997","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2005.10.052_bib45","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/IAI.62.1.229-235.1994","article-title":"Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum","volume":"62","author":"Pinelli","year":"1994","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2005.10.052_bib46","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1128\/IAI.67.11.5848-5853.1999","article-title":"Coadministration of interleukin 12 expression vector with antigen 2 cDNA enhances induction of protective immunity against Coccidioides immitis","volume":"67","author":"Jiang","year":"1999","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2005.10.052_bib47","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/(SICI)1521-4141(199803)28:03<1089::AID-IMMU1089>3.0.CO;2-L","article-title":"Modulation of amplitude and direction of in vivo immune responses by coadministration of cytokine gene expression cassettes with DNA immunogens","volume":"28","author":"Kim","year":"1998","journal-title":"Eur J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2005.10.052_bib48","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.4049\/jimmunol.158.10.4591","article-title":"Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines","volume":"158","author":"Iwasaki","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2005.10.052_bib49","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1146\/annurev.immunol.18.1.927","article-title":"DNA vaccines: immunology, application, and optimization","volume":"18","author":"Gurunathan","year":"2000","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2005.10.052_bib50","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0304-4017(00)00312-5","article-title":"Infection of a canine macrophage cell line with Leishmania infantum: determination of nitric oxide production and anti-leishmanial activity","volume":"92","author":"Pinelli","year":"2000","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2005.10.052_bib51","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0065-2776(08)60912-8","article-title":"The host response to Leishmania infection","volume":"74","author":"Solbach","year":"2000","journal-title":"Adv Immunol"},{"issue":"31","key":"10.1016\/j.vaccine.2005.10.052_bib52","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1016\/S0264-410X(03)00504-8","article-title":"Rabies DNA vaccine in the horse: strategies to improve serological responses","volume":"21","author":"Fischer","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.10.052_bib53","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1016\/j.vaccine.2004.04.015","article-title":"Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis","volume":"22","author":"Iborra","year":"2004","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2005.10.052_bib54","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-3024.1987.tb00492.x","article-title":"The correlation between delayed hypersensitivity, lymphocyte activation and protective immunity in experimental murine leishmaniasis","volume":"9","author":"De Rossell","year":"1987","journal-title":"Parasite Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2005.10.052_bib55","first-page":"438","article-title":"Effect of CD4 monoclonal antibody in vivo on lesion development, delayed-type hypersensitivity and interleukin 3 production in experimental murine cutaneous leishmaniasis","volume":"75","author":"Liew","year":"1989","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2005.10.052_bib56","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1017\/S0950268800057964","article-title":"Cutaneous leishmaniasis in the Peruvian Andes: an epidemiological study of infection and immunity","volume":"114","author":"Davies","year":"1995","journal-title":"Epidemiol Infect"},{"issue":"2","key":"10.1016\/j.vaccine.2005.10.052_bib57","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/00034983.1971.11686746","article-title":"Natural and experimental re-infection of man with Oriental sore","volume":"65","author":"Guirges","year":"1971","journal-title":"Ann Trop Med Parasitol"},{"issue":"5","key":"10.1016\/j.vaccine.2005.10.052_bib58","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0264-410X(98)00220-5","article-title":"A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran","volume":"17","author":"Momeni","year":"1999","journal-title":"Vaccine"},{"issue":"9241","key":"10.1016\/j.vaccine.2005.10.052_bib59","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(00)03128-7","article-title":"Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan","volume":"356","author":"Khalil","year":"2000","journal-title":"Lancet"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2005.10.052_bib60","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0304-4017(93)90195-S","article-title":"Immunological and histological study of T- and B-lymphocyte activity in canine visceral leishmaniosis","volume":"51","author":"Martinez-Moreno","year":"1993","journal-title":"Vet Parasitol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2005.10.052_bib61","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0165-2427(95)05434-8","article-title":"Humoral and cell-mediated immunity in natural and experimental canine leishmaniasis","volume":"48","author":"Martinez-Moreno","year":"1995","journal-title":"Vet Immunol Immunopathol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2005.10.052_bib62","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-4017(00)00223-5","article-title":"The Ibizian hound presents a predominantly cellular immune response against natural Leishmania infection","volume":"90","author":"Solano-Gallego","year":"2000","journal-title":"Vet Parasitol"},{"issue":"6","key":"10.1016\/j.vaccine.2005.10.052_bib63","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1002\/eji.1830250619","article-title":"Leishmania infantum-specific T cell lines derived from asymptomatic dogs that lyse infected macrophages in a major histocompatibility complex-restricted manner","volume":"25","author":"Pinelli","year":"1995","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2005.10.052_bib64","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1128\/AAC.40.1.253","article-title":"Canine visceral leishmaniasis: successful chemotherapy induces macrophage antileishmanial activity via the l-arginine nitric oxide pathway","volume":"40","author":"Vouldoukis","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.vaccine.2005.10.052_bib65","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/sj.gt.3302139","article-title":"Reduced immunogenicity of DNA vaccine plasmids in mixtures","volume":"11","author":"Sedegah","year":"2004","journal-title":"Gene Ther"},{"issue":"1","key":"10.1016\/j.vaccine.2005.10.052_bib66","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1128\/IAI.69.1.245-251.2001","article-title":"Vervet monkeys vaccinated with killed Leishmania major parasites and interleukin-12 develop a type 1 immune response but are not protected against challenge infection","volume":"69","author":"Gicheru","year":"2001","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2005.10.052_bib67","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1002\/eji.1830250816","article-title":"Early parasite containment is decisive for resistance to Leishmania major infection","volume":"25","author":"Laskay","year":"1995","journal-title":"Eur J Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2005.10.052_bib68","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.4049\/jimmunol.147.9.3149","article-title":"IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis","volume":"147","author":"Scott","year":"1991","journal-title":"J Immunol"},{"issue":"26","key":"10.1016\/j.vaccine.2005.10.052_bib69","doi-asserted-by":"crossref","first-page":"12932","DOI":"10.1073\/pnas.91.26.12932","article-title":"Interferon gamma-independent effects of interleukin 12 administered during acute or established infection due to Leishmania major","volume":"91","author":"Wang","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1016\/j.vaccine.2005.10.052_bib70","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.4049\/jimmunol.158.8.3635","article-title":"Contribution of CpG motifs to the immunogenicity of DNA vaccines","volume":"158","author":"Klinman","year":"1997","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2005.10.052_bib71","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0966-842X(97)01145-1","article-title":"The role of CpG dinucleotides in DNA vaccines","volume":"6","author":"Krieg","year":"1998","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2005.10.052_bib72","doi-asserted-by":"crossref","unstructured":"Saldarriaga OA, Perez LE, Travi BL, Melby PC. Selective enhancement of the type 1 cytokine response by expression of a canine interleukin (IL)-12 fused heterodimeric DNA. Vet Immunol Immunopathol [in press].","DOI":"10.1016\/j.vetimm.2005.11.003"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05010984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05010984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T10:20:26Z","timestamp":1683282026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X05010984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":72,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0264410X05010984"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.10.052","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}